Medicine Description
Ambezim-G contains trypsin & chymotrypsin, pancreatic enzymes, which are administered in a form & dosage favouring an adequate absorption from the intestinal tract. Ambezim-G reduces the intensity of inflammation, attenuates the pain, helps in the resolution of oedema & exudate & favours the penetration of antibacterial agents in the affected areas. Ambezim-G is therefore useful in infective & traumatic conditions accompanied by a local inflammatory reaction where it will accelerate recovery & limit fibrosis & adhesions. Pharmacokinetics: Trypsin & chymotrypsin are absorbed after oral dosage administration. They are formulated as enteric coated tablets to resist gastric juice but dissolve in the higher pH of the small intestine & release the dose of enzyme at this point. Indications: Resorption of post-traumatic & post-operative oedema & exudate. Adjunctive therapy in localised inflammatory conditions such as: Phlebitis, thrombophlebitis, decubitus ulcers.